There's a new player on the antibody-drug conjugate (ADC) scene. UK-based Pheon Therapeutics has entered stage right with $68 million in funding that will be used to fund development of a pipeline ...

Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced non ...

This article presents a 1.75-GS/s single-channel 7-bit successive approximation register (SAR) analog-to-digital converter (ADC) that is based on loop-unrolled architecture with N-comparators for ...

A 60-GS/s 7b 64-way time interleaved (TI) analog-to-digital converter (ADC) with analog front end (AFE) is described. The presented converter features a non-binary partial loop unrolled (LU) SAR ...